focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChina Pacific Regulatory News (CPIC)

Share Price Information for China Pacific (CPIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.30
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.70 (3.804%)
Open: 17.30
High: 0.00
Low: 0.00
Prev. Close: 17.30
CPIC Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of the 2020 Annual General Meeting

23 Apr 2021 13:00

RNS Number : 4673W
China Pacific Insurance Grp Co. Ltd
23 April 2021
 

 

23 April 2021

CHINA PACIFIC INSURANCE (GROUP) CO., LTD.

(A joint stock company incorporated in the People's Republic of China with limited liability)

Notice of the 2020 Annual General Meeting

 

NOTICE IS HEREBY GIVEN that the annual general meeting ("AGM" or "Annual General Meeting") of China Pacific Insurance (Group) Co., Ltd. (the "Company" or "CPIC") will be held at InterContinental Shenzhen Dameisha Resort, Shenzhen, Guangdong, the PRC, on Friday, 28 May 2021 at 1:30 p.m., for the purpose of considering, and if thought fit, passing the following resolutions.

 

AS ORDINARY RESOLUTIONS:

 

1. To consider and approve the report of the Board of Directors of the Company for the year 2020

 

2. To consider and approve the report of the Board of Supervisors of the Company for the year 2020

 

3. To consider and approve the annual reports of the Company for the year 2020

 

4. To consider and approve the financial statements and report of the Company for the year 2020

 

5. To consider and approve the profit distribution plan of the Company for the year 2020

 

6. To consider and approve the proposal on the appointment of auditors of the Company for the year 2021

 

7. To consider and approve the due diligence report of the Directors of the Company for the year 2020

 

8. To consider and approve the report on performance of Independent Directors of the Company for the year 2020

 

9. To consider and approve the donations for the year 2021 of the Company

 

AS SPECIAL RESOLUTIONS:

 

10. To consider and approve the change of the registered capital of the Company from RMB 9,062,000,000 to RMB 9,620,341,455

 

11. To consider and approve the proposed amendments to the Articles of Association of the Company in the manner stipulated in the section entitled "10. Proposed Amendments to the Articles of Association and the Rules of Procedure for Shareholders' General Meetings" as set out in Appendix I and to authorise the chairman or his authorised person to make such revisions to the proposed amendments to the Articles of Association as he deems necessary and appropriate in accordance with the requirements of regulatory authorities during the Company's approval process for the amended Articles of Association

 

12. To consider and approve the proposed amendments to the rules of procedure for Shareholders' general meetings in the manner stipulated in the section entitled "10. Proposed Amendments to the Articles of Association and the Rules of Procedure for Shareholders' General Meetings" as set out in Appendix I and to authorise the chairman or his authorised person to make such revisions to the proposed amendments to the rules of procedure for Shareholders' general meetings as he deems necessary and appropriate in accordance with the requirements of regulatory authorities during the Company's approval process for the amended rules of procedure for Shareholders' general meetings

 

13. As special business, to authorise the Board of Directors of the Company to determine if the Company shall allot, issue and deal with, A Shares and H Shares, separately or concurrently, according to market conditions and the needs of the Company, provided that the respective number of shares shall not exceed 20% of each of the A Shares or H Shares of the Company in issue on the date of the passing of this special resolution. However, notwithstanding the granting of the general mandate to the Board of Directors, any issue of new A Shares would require another shareholders' approval at a Shareholders' meeting in accordance with the relevant PRC laws and regulations

 

(1) Subject to paragraphs (3) and (4) below and pursuant to the Company Law of the People's Republic of China (the "Company Law") and the relevant regulatory stipulations (as amended from time to time) of the places where the shares of the Company are listed, the Board of Directors shall be granted a general and unconditional mandate to exercise all the powers of the Company to allot, issue and deal with new shares during the Relevant Period (as hereinafter defined) and to determine the terms and conditions for the allotment and issue of new shares which include, without limitation, the following terms:

 

(a) the class and number of new shares to be issued;

 

(b) the method of determining the issue price and/or the issue price (including the price range of new Shares);

 

(c) the starting and closing dates for the issue;

 

(d) class and number of the new shares to be issued to existing shareholders; and

 

(e) the making or granting of offers, agreements and options which might require the exercise of such powers.

 

(2) The approval in paragraph (1) shall authorise the Board of Directors during the Relevant Period to make or grant offers, agreements and options which would or might require the exercise of such powers after the end of the Relevant Period.

 

(3) The aggregate nominal amount of the new A Shares and new H Shares allotted, issued and dealt with conditionally or unconditionally (whether pursuant to an option or otherwise) by the Board of Directors pursuant to the approval in paragraph (1), other than the shares issued pursuant to a Rights Issue (as hereinafter defined) or the rights to purchase the shares of the Company under any option scheme or similar arrangement, shall not exceed 20% of each of the A Shares and H Shares of the Company in issue as at the date of passing this resolution.

 

(4) In exercising the powers granted in paragraph (1), the Board of Directors must (a) comply with the Company Law and the relevant regulatory stipulations (as amended from time to time) of the places where the shares of the Company are listed; and (b) obtain approval from China Securities Regulatory Commission and other relevant PRC government departments.

 

(5) For the purpose of this resolution:

 

"Relevant Period" means the period from the date of passing this resolution until the earliest of:

 

(a) the conclusion of the next annual general meeting of the Company;

 

(b) the expiration of the 12-month period following the passing of this resolution; and

 

(c) the revocation or variation of the mandate granted under this resolution by a special resolution of the Company's shareholders in a general meeting.

 

"Rights Issue" means the allotment or issue of shares in the Company or other securities which would or might require shares to be allotted and issued pursuant to an offer made to all the shareholders of the Company (excluding for such purpose any shareholder who is resident in a place where such offer is not permitted under the law of that place) and, where appropriate, the holders of other equity securities of the Company entitled to such offer, pro rata (apart from fractional entitlements) to their existing holdings of shares or such other equity securities.

 

(6) The Board of Directors, subject to the approval of the relevant authorities of the PRC and in accordance with the Company Law, shall be authorised to increase the registered capital of the Company to the required amount upon the exercise of the powers pursuant to paragraph (1) above.

 

(7) The Board of Directors shall be authorised to sign the necessary documents, complete the necessary formalities and take other necessary steps to complete the allotment, issue and listing of new shares, provided that the same do not violate the relevant laws, administrative regulations, and regulatory stipulations (as amended from time to time) of the places where the shares of the Company are listed, and the Articles of Association.

 

(8) Subject to the approval of the relevant PRC authorities, the Board of Directors shall be authorised to make amendments to the Articles of Association as appropriate and necessary after the completion of the allotment and issue of new shares according to the method of the allotment and issue of new shares by the Company, the type and number of new shares to be allotted and issued by the Company, and the actual shareholding structure of the Company at the time of completion of the allotment and issue of new shares, in order to reflect the changes in the share capital structure and the registered capital of the Company pursuant to the exercise of this mandate.

 

 

For details on above resolutions, please see the Appendices at http://www.rns-pdf.londonstockexchange.com/rns/4673W_1-2021-4-23.pdf

 

By Order of the Board of Directors

China Pacific Insurance (Group) Co., Ltd.

KONG Qingwei

Chairman

 

 

 

About CPIC

CPIC is a joint stock company established under the laws of the People's Republic of China with limited liability.

CPIC's registered office is located at 1 South Zhongshan Road, Huangpu District, Shanghai, the People's Republic of China.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAUOORRAOUSUAR
Date   Source Headline
13th May 20249:53 amRNSAnnouncement relating to Premium Income
7th May 20247:00 amRNSNotice of the 2023 AGM
7th May 20247:00 amRNSApproval of Articles of Association by NFRA
26th Apr 202412:04 pmRNSPublication of Summaries of Solvency Reports
26th Apr 202412:01 pmRNS2024 First Quarter Report
22nd Apr 202410:49 amRNS2023 Sustainability Report
15th Apr 202410:01 amRNSAnnouncement relating to Premium Income
11th Apr 20249:43 amRNSResignation of a Proposed Supervisor
8th Apr 20247:00 amRNSApproval of Director's Appointment Qualification
28th Mar 20243:58 pmRNSPublication of Summaries of Solvency Reports
28th Mar 20243:51 pmRNSPublication of 2023 Annual Results Presentation
28th Mar 20243:46 pmRNSCPIC 2023 Annual Report
21st Mar 202410:29 amRNSConvening of 2023 Annual Results Presentation
14th Mar 20249:28 amRNSAnnouncement relating to Premium Income
29th Feb 20242:09 pmRNSAnnouncement relating to election and appointment
29th Feb 20242:06 pmRNSAnnouncement on Poll Results for the EGM
29th Feb 20241:42 pmRNSAnnouncement relating to resignation of supervisor
19th Feb 20249:30 amRNSAnnouncement relating to Premium Income
19th Feb 20247:00 amRNSApproval of Director's Appointment Qualification
5th Feb 20249:17 amRNSNotice of EGM
29th Jan 20241:41 pmRNSApproval of Appointment Qualification
29th Jan 20241:34 pmRNSChange of President
29th Jan 20241:31 pmRNSResignation of Chairman of the Board
16th Jan 20249:36 amRNSAnnouncement relating to Premium Income
15th Dec 20238:26 amRNSAnnouncement relating to Premium Income
11th Dec 202310:44 amRNSProposed amendments to the Articles of Association
27th Nov 202311:03 amRNSPoll Results for the EGM
16th Nov 20239:22 amRNSAnnouncement relating to Premium Income
9th Nov 20238:46 amRNSNotice of EGM
9th Nov 20238:37 amRNSPDMR Shareholding
27th Oct 202312:18 pmRNSResignation of Director
27th Oct 202312:11 pmRNSPublication of Summaries of Solvency Reports
27th Oct 202312:01 pmRNSCPIC 2023 Third Quarter Report
20th Oct 202310:33 amRNS2023 Q3 Results Presentation
17th Oct 202311:00 amRNSAnnouncement relating to Premium Income
13th Sep 20239:43 amRNSAnnouncement relating to Premium Income
29th Aug 20237:00 amRNSPublication of Summaries of Solvency Reports
29th Aug 20237:00 amRNSPublication of 2023 Interim Results Presentation
29th Aug 20237:00 amRNS2023 Interim Report
17th Aug 202310:59 amRNSConvening of 2023 Interim Results Presentation
14th Aug 202310:21 amRNSAnnouncement relating to Premium Income
3rd Aug 20239:45 amRNSAppointment of Member of Committees of the Board
21st Jul 20233:03 pmRNSApproval of Director's Appointment Qualification
14th Jul 20239:44 amRNSAnnouncement relating to Premium Income
4th Jul 20237:30 amRNSPDMR Shareholding
3rd Jul 202311:30 amRNSDisclosure of Presentations on 2023 Investor Day
28th Jun 202311:29 amRNSDirector/PDMR Shareholding
28th Jun 202311:26 amRNSDirector/PDMR Shareholding
14th Jun 202310:04 amRNSAnnouncement relating to Premium Income
13th Jun 202310:57 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.